Drug
J591 monoclonal antibody clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2009
How studies write it
Studies that test it under each name
Combined with it in one product
- J591
- 1
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
Weill Medical College of Cornell University (2) · BZL Biologics (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses J591 monoclonal antibody is read from its arms, and is right about nine times in ten.
Testing it · 3
- 177Lu Radiolabeled Monoclonal Antibody HuJ591 (177Lu-J591) and Ketoconazole in Patients With Prostate CancerActive, not recruitingPhase 2Weill Medical College of Cornell UniversityNCT00859781Written as 177Lu-J591
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid TumorsCompletedPhase 1Weill Medical College of Cornell UniversityNCT00967577Written as 177Lu-J591
- Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2CompletedPhase 2BZL BiologicsNCT00040586Written as Monoclonal Antibody J591
Codes
What other systems call J591 monoclonal antibody · ClinicalTrials.gg INT004574
- MeSH (NLM) C478680J591 monoclonal antibodyOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C478680 | J591 monoclonal antibody | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.